Dr. Ramesh Kancharla has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.
RAINBOW · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Dr. Ramesh Kancharla, on behalf of all promoters and promoter group entities of Rainbow Childrens Medicare, has filed a declaration confirming that neither he nor any person acting in concert created any encumbrance (pledge, lien, or charge) on the shares held by them during the financial year ended March 31, 2025. The disclosure covers six promoter/promoter group entities, including Dr. Dinesh Kumar Chirla, Dr. Adarsh Kancharla, the Kancharla Family Trust, the Sai Geeta Dinesh Trust, Mr. Ramadhara Naidu Kancharla, and Mr. Srinivas Talasila. This is a routine annual compliance filing required under SEBI's takeover regulations for promoters and promoter groups.
This is a neutral-to-slightly-positive confirmation that promoters have not pledged or encumbered their shares during the year, signalling no immediate financial stress at the promoter level. It is a compliance filing and is unlikely to move the stock price materially.